Diabetes and cardiovascular disease

Barbé Illa, MD F., Madrid, Spain OSA and cardiovascular risk

Schnell, Prof. O., Munich, Germany Self-monitoring of blood glucose – to be or not to be in non-insulin treated patients

Standl, Prof. E., Munich, Germany Compensating for the effect of glycemic worsening drugs, e.g. statins

Rydén, Prof. L., Stockholm, Sweden Blood glucose lowering drugs: old problems, new promises

Holman, Prof. R., Oxford, United Kingdom Estimating individual CVD risk in Type 2 diabetes

Schnell, Prof. O., Munich, Germany Self-monitoring of blood glucose: Impact on CV risk in diabetes

Hanefeld, Prof. M., Dresden, Germany Patterns of continuous glucose monitoring: A role for prediction or cardiac arrhythmias?

Standl, Prof. E., Munich, Germany Statin and RAAS inhibitor for every diabetic patient?

Ceriello, Prof. A., Barcelona, Spain The need for individualized medicine in diabetes

Comaschi, Prof. M., Genoa, Italy Left ventricular dysfunction in diabetes (the DYDA Study)

Standl, Prof. E., Munich, Germany CVD outcome studies in diabetes

Wilding, Prof. J., Liverpool, United Kingdom Sleep-disordered breathing and cardio-metabolic disease

Marx, Prof. N., Ulm, Germany Potentials for cardioprotection

Tschöpe, Prof. D., Bad Oeynhausen, Germany Silent diabetes and silent CAD: two sides of the same coin?

Roden, Prof. M., Duesseldorf, Germany Mitochondrial dysfunction and type 2 diabetes: pathways for cardiovascular complications

Bengel, Prof. F. M., Hannover, Germany Molecular, neuronal and metabolic imaging of the diabetic heart

Valensi, P., France Diabetic cardiac autonomic neuropathy: does it really matter?

Vergès, Prof. B., Dijon, France Cardiac rehabilitation in diabetes

Conget, Dr. I., Barcelona, Spain Hypoglycemia as an aggravating factor of atherosclerosis

Tuomilehto, Prof. J., Helsinki, Finland Genome-wide association data and CV risk

Kintscher, Prof. U., Germany The future of treatment of hypertension in diabetes

Ji, Prof. L., Peking, China Diabetes and CVD in China

Ceriello, Prof. A., Barcelona, Spain Improving cardiovascular outcome by reducing glycemic variability and post-prandial glucose excursions

Holst, Prof. J. J., Copenhagen, Denmark Going beyond conventional therapies: an update on DPP-4 inhibition

Bosi, Prof. E., Milan, Italy Implementing "Structured Testing" of blood glucose in Italy: The PRISMA study

Schnell, Prof. O., Munich, Germany A Case Presentation on type 2 diabetes and coronary artery disease

Standl, Prof. E., Munich, Germany Type 2 Diabetes: Should it still be considered as an Equivalent of Coronary Heart Disease?! - YES -

Standl, Prof. E., Munich, Germany Type 2 Diabetes: Should it still be considered as an Equivalent of Coronary Heart Disease?! - YES - Rebuttal

Tschöpe, Prof. D., Bad Oeynhausen, Germany CV benefits of GLP-1 analogues and DPP-IV inhibitors: Fact or myth?

Schnell, Prof. O., Munich, Germany Hypoglycemia: The neglected complication?

Hanefeld, Prof. M., Dresden, Germany HbA1c for diagnosis of diabetes: What are we gaining, what are we loosing?

Standl, Prof. E., Munich, Germany Cardio-metabolic interactions and side effects of multifactorial risk management

Zimmet, Prof. P., Mellbourne, Australia HbA1c for Diagnosis of Diabetes – What are we gaining, what are we losing?(Archiv) 19-Oct-09

Ceriello, Prof. A., Barcelona, Spain Is HbA1c sufficient for the evaluation of hyperglycemia-related CVD risk in diabetes?(Archiv) 19-Oct-09

Tuomilehto, Prof. J., Helsinki, Finland Hypoglycemia as a CV-risk factor(Archiv) 19-Oct-09

Ceriello, Prof. A., Barcelona, Spain Postprandial hyperglycaemia as a driving force in diabetes and CVD(Archiv) 18-Oct-09

Holman, Prof. R., Oxford, United Kingdom The Acarbose Cardiovascular Evaluation (ACE) study - secondary prevention of CVD in prediabetes(Archiv) 18-Oct-09

Chiasson, Prof. J.-L., Montréal, Canada Glucose lowering interventions in diabetes and CVD - lessons from outcome studies(Archiv) 18-Oct-09

Josse, Prof. R., Toronto, Canada Acarbose - safe and effective glycaemic control with cardiovascular benefits(Archiv) 18-Oct-09

Schnell, Prof. O., Munich, Germany Recent guideline recommendations for managing pre- and established diabetes and CVD(Archiv) 18-Oct-09

Chiasson, Prof. J.-L., Montréal, Canada Summary and conclusions(Archiv) 18-Oct-09

Erdmann, Prof. E., Köln, Germany Acute Treatment of Cardiovascular Disease(Archiv) 29-Aug-08

Böhm, Prof. M., Homburg/Saar, Germany Heart Failure in Diabetes(Archiv) 29-Aug-08

Ceriello, Prof. A., Barcelona, Spain Postpranial hyperclycaemia as a driving force in diabetes and CVD - epidemiological evidence & molecular insights(Archiv) 01-Jun-08

Rydén, Prof. L., Stockholm, Sweden Two sides of the same coin - guideline recommendations for managing diabetes and CVD(Archiv) 01-Jun-08

Satman, Prof. I., Turkey Screening and intervention programmes to prevent diabetes and CVD - an example from daily practice(Archiv) 01-Jun-08

Jellinger, Dr. P., Miami, United States Target Glycaemic Control: Two Experts` Perspectives(Archiv) 17-Oct-07

Gerstein, Prof. H. C., Hamilton, Canada Glycemic Control & CVD: What does the Evidence Show? What answers are on the Horizon?(Archiv) 17-Oct-07

Kaufman, MD F., Childrens Hospital Los Angeles, Los Angeles, United States Our Children with Diabetes: Hearts at Risk(Archiv) 27-Sep-07

Standl, Prof. E., Munich, Germany New Coaching Techniques(Archiv) 18-Sep-07

Holman, Prof. R., Oxford, United Kingdom CVD Risk Reduction In Prediabetes - Impact of Recent Studies and of the ACARBOSE CARDIOVASCULAR EVALUATION (ACE) Trial(Archiv) 17-Sep-07

Chiasson, Prof. J.-L., Montréal, Canada Managing Dysglycemia And CVD - Exploring Current Treatment Options(Archiv) 17-Sep-07

Rosas, Dr. J., Mexico Latin American Experience(Archiv) 17-Sep-07

Chiasson, Prof. J.-L., Montréal, Canada North American Experience(Archiv) 17-Sep-07

Shaw, Dr. J., Australia Asian Experience(Archiv) 17-Sep-07

Tuomilehto, Prof. J., Helsinki, Finland European Experience(Archiv) 17-Sep-07

Bartnik, Dr. M., Stockholm, Sweden Definition and classification of diabetes and pre-diabetic glucose abnormalities(Archiv) 29-Jun-07

Tuomilehto, Prof. J., Helsinki, Finland Identification of subjects at high risk for cardiovascular disease or diabetes(Archiv) 29-Jun-07

Standl, Prof. E., Munich, Germany Treatment to reduce cardiovascular risk: Life style counselling and glycemic control(Archiv) 29-Jun-07

Östergren, Prof. J., Stockholm, Sweden Treatment to reduce cardiovascular risk: Hypertension and dyslipidemia(Archiv) 29-Jun-07

Malmberg, Prof. K., Stockholm, Sweden Management of cardiovascular diseases: Acute coronary syndromes(Archiv) 29-Jun-07

Rydén, Prof. L., Stockholm, Sweden Management of cardiovascular disease: Coronary interventions(Archiv) 29-Jun-07

Östergren, Prof. J., Stockholm, Sweden Management of cardiovascular diseases: Peripheral and cerebrovascular disease(Archiv) 29-Jun-07

Vahanien, Prof. A., Paris, France Guideline distribution and adherence in a general perspective(Archiv) 29-Jun-07

Chiasson, Prof. J.-L., Montréal, Canada Acarbose – a proven role in prediabetes and beyond(Archiv) 03-Dec-06

Holman, Prof. R., Oxford, United Kingdom CVD risk reduction in prediabetes – current and future outcome trials(Archiv) 03-Dec-06

Rydén, Prof. L., Stockholm, Sweden Dysglycaemia and CVD – the deadly duo(Archiv) 03-Dec-06

Hu, Prof. D., Peking, China Halting disease progression – the need for early intervention(Archiv) 03-Dec-06

Chiasson, Prof. J.-L., Montréal, Canada Glucobay® – treating dysglycaemia and reducing CVD risk(Archiv) 03-Dec-06

Holman, Prof. R., Oxford, United Kingdom A new outcome trial with Glucobay® – further investigation in diabetes and CVD prevention(Archiv) 03-Dec-06

Ruilope, Prof. L., Madrid, Spain Nifedipine GITS - a time for ACTION in diabetes patients(Archiv) 05-Sep-04

Alberti, Prof. Sir G., London, United Kingdom Type 2 Diabetes and CVD - a tale of two diseases?(Archiv) 05-Sep-04

Haffner, Prof. S., San Antonio, United States Acarbose - a first-line therapy to break the CVD connection(Archiv) 05-Sep-04

Armitage, Prof. J., Oxford, United Kingdom The role of Aspirin™ for CV risk reduction in diabetes(Archiv) 05-Sep-04

Hanefeld, Prof. M., Dresden, Germany Normalizing glucose metabolism along the diabetes continuum - benefits beyond metabolic control(Archiv) 28-Aug-03

Holman, Prof. R., Oxford, United Kingdom Chairman´s welcome and objectives(Archiv) 28-Aug-03

Josse, Prof. R., Toronto, Canada Reducing the risk of cardiovascular events in diabetes - evidence based options(Archiv) 28-Aug-03

Karasik, Prof. A., Tel Hashomer, Israel Prevention of CV events in diabetics by antiplatelet therapy(Archiv) 28-Aug-03